Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805306 · ClinicalTrials.gov registry record · NA
Entre Herman@s: Promoting Health Among Latino MSM
A NA study of HIV Infections, sponsored by Charles Drew University of Medicine and Science.
- Active
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 1
- Study location
NCT05805306: Active NA study of HIV Infections, sponsored by Charles Drew University of Medicine and Science.
NCT05805306 is a NA study of HIV Infections that is active but no longer recruiting, run by Charles Drew University of Medicine and Science. The registered enrollment target is 288 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05805306, a NA study of HIV Infections, is active but no longer recruiting, sponsored by Charles Drew University of Medicine and Science.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial with an attention placebo control group. The goal of this study is to decrease HIV incidence in Latino men who have sex with men by engaging their siblings in PrEP-use promotion. In the intervention arm, siblings will be trained to engage their gay brother in PrEP conversations. In the control arm, siblings will be trained to engage their gay brother in conversations about vaccines to prevent COVID, Hepatitis A/B, or MPOX.
Primary Outcome
This measures how many participants in the experiment group started taking PrEP (baseline = 0 participants). Tool: Pictures. Participants will submit a picture of their pill bottle to report PrEP use.
Conditions Studied
Interventions
- BEHAVIORAL Entre Herman@s
- BEHAVIORAL Vaccines for Health
Study Locations (1)
California
- Charles R. Drew University of Medicine and Science - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2023-04-29 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the registry record for NCT05805306 still lists
NCT05805306 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Entre Herman@s is the first listed.
NCT05805306 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05805306 about?
NCT05805306 is a clinical study titled "Entre Herman@s: Promoting Health Among Latino MSM". This is a randomized controlled trial with an attention placebo control group. The goal of this study is to decrease HIV incidence in Latino men who have sex with men by engaging their siblings in PrEP-use promotion. In the intervention arm, siblings will be trained to engage their gay brother in Pr...
What is the current status of trial NCT05805306?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2023-04-29. Estimated completion is 2025-06-30.
What conditions does trial NCT05805306 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT05805306?
The interventions under investigation include: Entre Herman@s (BEHAVIORAL), Vaccines for Health (BEHAVIORAL).
Who is sponsoring clinical trial NCT05805306?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805306 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05805306's enrollment target sits among peer trials
288 127th of 542 higher than 415 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI